Nuria Malats Riera

Title: Nuria Malats Riera: Innovator in Cancer Diagnosis

Introduction

Nuria Malats Riera is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of cancer diagnosis through her innovative research and inventions. Her work focuses on the development of biomarkers that can aid in the early detection and prognosis of bladder cancer.

Latest Patents

Nuria holds a patent for her invention titled "Bladder cancer biomarker proteins." This invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis. It includes an artificial protein comprising these signature peptides and a nucleic acid construct encoding for such an artificial protein. Additionally, the invention outlines a method for cancer diagnosis and/or prognosis that involves analyzing at least 10 proteins in a urine sample from a subject. Furthermore, it encompasses an immunoassay product that includes antibodies for detecting at least 10 proteins.

Career Highlights

Throughout her career, Nuria has worked with notable organizations, including Polyquant GmbH and Commissariat à l'énergie atomique et aux énergies alternatives. Her experience in these companies has allowed her to advance her research and contribute to the scientific community.

Collaborations

Nuria has collaborated with esteemed colleagues such as Jerome Garin and Christophe Masselon. These partnerships have further enriched her work and expanded the impact of her inventions.

Conclusion

Nuria Malats Riera is a trailblazer in the field of cancer diagnostics, with her innovative patent contributing to the early detection and prognosis of bladder cancer. Her work exemplifies the importance of research and innovation in improving healthcare outcomes.